obesity therapy (Hybrigenics/Lynx)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameobesity therapy (Hybrigenics/Lynx)
Drug Alias Nameadipogenesis regulator (Hybrigenics/Lynx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes MellitusLipodystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHybrigenics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSolexa IncHybrigenics SA
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusLipodystrophy

Other Information

ATC CodeN/A
Related LinksN/A